Literature DB >> 9751176

Glutamatergic regulation of basal and stimulus-activated dopamine release in the prefrontal cortex.

R Takahata1, B Moghaddam.   

Abstract

The present study was undertaken to determine whether basal and stimulus-activated dopamine release in the prefrontal cortex (PFC) is regulated by glutamatergic afferents to the PFC or the ventral tegmental area (VTA), the primary source of dopamine neurons that innervate the rodent PFC. In awake rats, blockade of NMDA or alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptors in the VTA, or blockade of AMPA receptors in the PFC, profoundly reduced dopamine release in the PFC, suggesting that the basal output of dopamine neurons projecting to the PFC is under a tonic excitatory control of NMDA and AMPA receptors in the VTA, and AMPA receptors in the PFC. Consistent with previous reports, blockade of cortical NMDA receptors increased dopamine release, suggesting that NMDA receptors in the PFC exert a tonic inhibitory control on dopamine release. Blockade of NMDA or AMPA receptors in the VTA as well as blockade of AMPA receptors in the PFC reduced the dopaminergic response to mild handling, suggesting that activation of glutamate neurotransmission also regulates stimulus-induced increase of dopamine release in the PFC. In the context of brain disorders that may involve cortical dopamine dysfunction, the present findings suggest that abnormal basal or stimulus-activated dopamine neurotransmission in the PFC may be secondary to glutamatergic dysregulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751176     DOI: 10.1046/j.1471-4159.1998.71041443.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  36 in total

1.  Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptors.

Authors:  Claude Sebban; Brigitte Tesolin-Decros; Jorge Ciprian-Ollivier; Laurent Perret; Michael Spedding
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 2.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 3.  Effect of stress on prefrontal cortex function.

Authors:  Bita Moghaddam; Mark Jackson
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

4.  Dynamic changes in extracellular release of GABA and glutamate in the lateral septum during social play behavior in juvenile rats: Implications for sex-specific regulation of social play behavior.

Authors:  R Bredewold; J K Schiavo; M van der Hart; M Verreij; A H Veenema
Journal:  Neuroscience       Date:  2015-08-28       Impact factor: 3.590

5.  Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments.

Authors:  A R Owolabi; M A Akanmu; O E Ukponmwan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-12       Impact factor: 3.000

6.  Amphetamine stimulates movement through thalamocortical glutamate release.

Authors:  Omar S Mabrouk; Daniel Z Semaan; Sarah Mikelman; Margaret E Gnegy; Robert T Kennedy
Journal:  J Neurochem       Date:  2013-08-19       Impact factor: 5.372

7.  MK-801-induced behavioural sensitisation alters dopamine release and turnover in rat prefrontal cortex.

Authors:  Xiaoying Cui; Emilia Lefevre; Karly M Turner; Carlos M Coelho; Suzy Alexander; Thomas H J Burne; Darryl W Eyles
Journal:  Psychopharmacology (Berl)       Date:  2014-07-29       Impact factor: 4.530

8.  What is schizophrenia: A neurodevelopmental or neurodegenerative disorder or a combination of both? A critical analysis.

Authors:  Swapnil Gupta; Parmanand Kulhara
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

9.  Burst activation of dopamine neurons produces prolonged post-burst availability of actively released dopamine.

Authors:  Sweyta Lohani; Adria K Martig; Suzanne M Underhill; Alicia DeFrancesco; Melanie J Roberts; Linda Rinaman; Susan Amara; Bita Moghaddam
Journal:  Neuropsychopharmacology       Date:  2018-05-07       Impact factor: 7.853

Review 10.  Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.

Authors:  John R Mantsch; David A Baker; Douglas Funk; Anh D Lê; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2015-05-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.